Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia

Neuron

Volumn 19, Issue 1, 1997, Pages 115-126

  Saiardi, Adolfo ^a   Bozzi, Yuri ^a   Baik, Ja Hyun ^a,b   Borrelli, Emiliana ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; ESTROGEN; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCRINE DISEASE; ESTROGEN BLOOD LEVEL; FEMALE; HYPERPLASIA; HYPOPHYSIS DISEASE; MALE; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN SECRETING CELL; SEX DIFFERENCE;

EID: 0030808990     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80352-9     Document Type: Article

References (59)

1. Abe, H., Engler, D., Molitch, M.E., Bollinger-Gruber, J., and Reichlin, S. (1985). Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 116, 1383-1388.
2. Akerblom, I.E, Ridgway, E.C., and Mellon, P.L. (1990). An alpha-subunit-secreting cell line derived from a mouse thyrotrope tumor. Mol. Endocrinol. 4, 589-596.
3. Andersen, B., and Rosenfeld, M.G. (1994). Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J. Biol. Chem. 269, 29335-29338.
4. 2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitary. Mol. Cell. Endocrinol. 67, 101-105.
5. 2 receptor. Nature 377, 424-428.
6. Bansal, S., Lee, L.A., and Woolf, P.D. (1981). Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients. Am. J. Med. 71, 961-970.
7. Behringer, R.R., Mathews, L.S., Palmiter, R.D., and Brinster, R.L. (1988). Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev. 2, 453-461.
8. Ben-Jonathan, N. (1994). Regulation of prolactin secretion. In The Pituitary Gland, Second Edition, H. Imura, ed. (New York: Raven Press), pp. 261-283.
9. Boockfor, F.R., Hoeffler, J.P., and Frawley, L.S. (1986). Estradiol induces a shift in cultured cells that release prolactin or growth hormone. Am. J. Physiol., 250, E103-E105.
10. Borrelli, E. (1994). Pitfalls during development: controlling differentiation of the pituitary gland. Trends Genet. 10, 222-224.
11. Borrelli, E., Heyman, R.A., Arias, C., Sawchenko, P.E., and Evans, R.M. (1989). Transgenic mice with inducible dwarfism. Nature 339, 538-541.
12. Borrelli, E., Sawchenko, P.E., and Evans, R.M. (1992). Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc. Natl. Acad. Sci. USA 89, 2764-2768.
13. Bossé, R., Fumagalli, F., Jaber, M., Giros, B., Gainetdinov, R.R., Wetsel, W.C., Missale, C., and Caron, M.G. (1997). Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19, this issue, 19, 127-138.
14. Boutin, J.M., Jolicoeur, C., Okamura, H., Gagnon, J., Edery, M., Shirota, M., Banville, D., Dusanter-Fourt, I., Djiane, J., and Kelly, P.A. (1988). Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53, 69-77.
15. Carbajo-Perez, E., and Watanabe, Y.G. (1990). Cellular proliferation in the anterior pituitary of the rat during the postnatal period. Cell Tissue Res. 267, 333-338.
16. Chen, C.L., Dionne, F.T., and Roberts, J.L. (1983). Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Proc. Natl. Acad. Sci. USA 80, 2211-2215.
17. Cote, T.E., Felder, R., Kebabian, J.W., Sekura, R.D., Reisine, T., and Affolter, H.U. (1986). D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase. J. Biol. Chem. 267, 4555-4561.
18. Day, R.N., Koike, S., Sakai, M., Muramatsu, M., and Maurer, R.A. (1990). Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol. Endocrinol. 4, 1964-1971.
19. Dorrington, J., and Gore-Langton, R.E. (1981). Prolactin inhibits oestrogen synthesis in the ovary. Nature 290, 600-603.
20. Elias, K.A., and Weiner, R.I. (1987). Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats. Endocrinology 720, 617-621.
21. 2 receptor-regulated expression of the prolactin gene. J. Biol. Chem. 266, 22919-22925.
22. Frawley, L.S., and Miller, H.A., III (1989). Ontogeny of prolactin secretion in the neonatal rat is regulated posttranscriptionally. Endocrinology 124, 3-6.
23. Frohman, L.A. (1987). Diseases of the anterior pituitary. In Endocrinology and Metabolism, Second Edition, P. Felig, J.D. Baxter, A.E. Broadus, and L.A. Frohman, eds. (New York: McGraw-Hill, Inc.), pp. 247-337.
24. Gage, P.J., Roller, M.L., Saunders, T.L., Scarlett, L.M., and Camper, S.A. (1996). Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development 122, 151-160.
25. Gao, J., Hughes, J.P., Auperin, B., Buteau, H., Edery, M., Zhuang, H., Wojchowski, D.M., and Horseman, N.D. (1996). Interactions among Janus kinase and the prolactin (PRL) receptor in the regulation of a PRL response element. Mol. Endocrinol. 10, 847-856.
26. Gingrich, J.A., and Caron, M.G. (1993). Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16, 299-321.
27. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., and Caron, M.G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
28. Godfrey, P., Rahal, J.O., Beamer, W.G., Copeland, N.G., Jenkins, N.A., and Mayo, K.E. (1993). GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat. Genet. 4, 227-232.
29. 2 receptor directs specificity of coupling to G-proteins. J. Biol. Chem. 270, 7354-7358.
30. 3H]-7-hydroxy-N, N-di-n-propyl-2-aminotetralin. Brain Res. 648, 222-228.
31. Jacobs, L.S., Snyder, P.J., Wilbur, J.F., Utiger, R., and Daughaday, W.H. (1971). Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J. Clin. Endocrinol. Metab. 33, 996-1002.
32. Jahn, G.A., Edery, M., Belair, L., Kelly, P.A., and Djiane, J. (1991). Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation. Endocrinology 128, 2976-2984.
33. Kendall, S.K., Samuelson, L.C., Saunders, T.L., Wood, R.I., and Camper, S.A. (1995). Targeted disruption of the pituitary glycoprotein hormonealpha-subunit produces hypogonadaland hypothyroid mice. Genes Dev. 9, 2007-2019.
34. Lebrun, J.J., Ali, S., Coffin, V., Ullrich, A., and Kelly, P.A. (1995). A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. USA 92, 4031-4035.
35. Li, S., and Pelletier, G. (1992). Role of dopamine in the regulation of gonadotropin-releasing hormone in the male rat brain as studied by in situ hybridization. Endocrinology 131, 395-399
36. Li, S., Crenshaw, E.B., III, Rawson, E.J., Simmons, D.M., Swanson, L.W., and Rosenfeld, M.G. (1990). Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 347, 528-533.
37. Lieberman, M., Slabaugh, M., Rutledge, J., and Gorski, J. (1983). The role of estrogen in the differentiation of prolactin producing cells. J. Steroid Biochem. Mol. Biol. 19, 275-281.
38. Lin, C., Lin, S.C., Chang, C.P., and Rosenfeld, M.G. (1992). Pit-1-dependent expression of the receptorfor growth hormone releasing factor mediates pituitary cell growth. Nature 360, 765-768.
39. Mayo, K.E. (1992). Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol. Endocrinol. 6, 1734-1744.
40. Mershon, J., Sall, W., Mitchner, N., and Ben-Jonathan, N. (1995). Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136, 3619-3623.
41. Missale, C., Losa, L., Sigala, S., Balsari, A., Giovannelli, M., and Spano, P. (1996a). Nerve Growth Factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Mol. Endocrinol. 10, 272-285.
42. Missale, C., Boroni, F., Sigala, S., Buriani, A., Fabris, M., Leon, A., Dal Toso, R., and Spano, P. (1996b). Nerve Growth Factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc. Natl. Acad. Sci. USA 93, 4240-4245.
43. 2 receptors and G-proteins. Mol. Endocrinol. 7, 161-170.
44. Morel, G., Ouhtit, A., and Kelly, P.A. (1994). Prolactin receptor immunoreactivity in rat anterior pituitary. Neuroendocrinology 59, 78-84.
45. 2 receptors in signal transduction and behavior. Crit. Rev. Neurobiol. 11, 121-142.
46. Pierce, J.G., and Parsons, T.F. (1981 ). Glycoprotein hormones:structure and function. Annu. Rev. Biochem. 50, 465-495.
47. Rhodes, S.J., Di Mattia, G.E., and Rosenfeld, M.G. (1994). Transcriptional mechanisms in anterior pituitary cell differentiation. Curr.Opin. Genet. Dev. 4, 709-717.
48. Rui, H., Kirken, R.A., and Farrar, W.L. (1994). Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269, 5364-5368.
49. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Second Edition (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory).
50. Schindler, C., and Darnell, J.E., Jr. (1995).Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651.
51. Seeman, P., and Van Tol, H.M. (1994). Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15, 264-270.
52. Segal, R.A., and Greenberg, M.E. (1996). Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-489.
53. Slabaugh, M.B., Lieberman, M.E., Rutledge, J.J., and Gorski, J. (1981). Growth hormone and prolactin synthesis in normal and homozygous Snell and Ames dwarf mice. Endocrinology 109, 1040-1046.
54. Sornson, M.W., Wu, W., Dasen, J.S., Flynn, S.E., Norman, D.J., O'Connell, S.M., Gukovsky, I., Carrière, C., Ryan, A.K., Miller, A.P., Zuo, L., Gleiberman, A.S., Andersen, B., Beamer, W.G., and Rosenfeld, M.G. (1996). Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327-333.
55. 4 receptor mRNA levels in rat brain and pituitary during aging. Neurobiol. Aging 15, 713-719.
56. Voss, J.W., and Rosenfeld, M.G. (1992). Anterior pituitary development: short tales from dwarf mice. Cell 70, 527-530.
57. Wang, C., Hsueh, A.J.W., and Erickson, G.F. (1980). Prolactin inhibits estrogen production by cultured rat granulosa cells. Mol. Cell. Endocrinol. 20, 135-142.
58. Weiner, R.I., Findell, P.R., and Kordon, C. (1988). Role of classic and peptide neuromediators in the neuroendocrine regulation of LH and prolactin. In The Physiology of Reproduction. E. Knobil and J. Neill, eds. (New York: Ravel Press, Ltd.), pp. 1235-1281.
59. 2 receptor and pituitary tumours. Clin. Endocrinol. 35, 455-466.